Volpara Health Technologies Limited provides breast imaging analytics and analysis products for the early detection of breast cancer in the medical device and practice management software industry. The company offers VolparaEnterprise software, a cloud-based breast imaging analytics platform that delivers real-time quality assurance and performance monitoring solutions; and VolparaDensity software, which provides volumetric breast density measurements and a breast density category. It also offers VolparaDose, which compute the personalized x-ray dose to the patient based on breast density; VolparaPressure that computes the compression pressure applied to the breast during a mammogram; VolparaScorecard+, a clinical decision-support tool that provides insights for breast care; VolparaLive, a real-time decision support system, which analyzes patient positioning and compression, and offers real-time feedback; and VolparaRisk, a risk assessment software that delivers objective insight to radiologists for supplemental screening and testing. In addition, the company provides Aspen Breast, a workflow driven tracking and reporting solution; and Aspen Lung, a lung screening workflow tool that facilitates lung CT screening reporting and data system. Volpara Health Technologies Limited operates in North America, Europe, the Middle East, Africa, and the APAC countries. The company was formerly known as Matakina Technology Ltd. and changed its name to Volpara Health Technologies Limited in October 2015. Volpara Health Technologies Limited was founded in 2009 and is headquartered in Wellington, New Zealand.
Read More
